Please provide your email address to receive an email when new articles are posted on . Acute and recurrent pericarditis require medical management to improve morbidity and quality of life. Aspirin, ...

(RTTNews) - Scilex Holding Co. (SCLX) announced that FDA has approved it request for the Orphan drug designation for colchicine for the treatment of pericarditis. Pericarditis is an inflammation of ...

Gloperba ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Pericarditis is an inflammation of the ...

Please provide your email address to receive an email when new articles are posted on . Advances in imaging techniques and new treatments are changing the management of recurrent pericarditis, ...

Scilex Holding Company announced that the FDA has granted orphan drug designation for the oral liquid version of colchicine, branded as Gloperba®, for treating pericarditis, an inflammation of the ...

Scilex Holding said the Food and Drug Administration granted orphan drug designation for colchicine for the treatment of pericarditis. The company's Gloperba, licensed from Romeg Therapeutics, is a ...

WASHINGTON, March 30 (Reuters) - A drug that was used in the time of the pharaohs for rheumatism has proven highly effective in treating recurrent bouts of pericarditis, an inflammation of the sac ...

Objective Colchicine, derived from autumn crocus ( Colchicum autumnale ), has been used for centuries to treat arthritis.

The earlier the anti-inflammatory drug colchicine is initiated after a myocardial infarction (MI) the greater the benefit, a new COLCOT analysis suggests. The parent trial was conducted in patients ...